{"nctId":"NCT01265446","briefTitle":"Efficacy and Safety of a Sore Throat Lozenge Containing Lidocaine and Cetylpyridinium Chloride in Patients With Sore Throat Due to a Common Cold.","startDateStruct":{"date":"2010-12"},"conditions":["Sore Throat Due to a Common Cold"],"count":250,"armGroups":[{"label":"Lidocaine 8mg +CPC 2mg","type":"EXPERIMENTAL","interventionNames":["Drug: Lidocaine 8mg + CPC 2mg"]},{"label":"Lidocaine 1mg + CPC 2mg","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Lidocaine 1mg + CPC 2mg"]}],"interventions":[{"name":"Lidocaine 8mg + CPC 2mg","otherNames":[]},{"name":"Lidocaine 1mg + CPC 2mg","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients with sore throat due to an upper respiratory tract infection, with recent onset (within 48 hours)\n* Sore throat of at least moderate pain intensity\n\nExclusion Criteria:\n\n* \\- History of hypersensitivity to any of the study drugs and listed excipients or to drugs of similar chemical classes\n* Evidence of mouth breathing or severe coughing\n* Evidence of overt oropharyngeal bacterial or fungal infection or evidence of lower respirator tract infection\n* Severe renal, liver or cardiac impairment\n* Severe lung disease","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change From Baseline Sore Throat Pain Intensity","description":"100 milimeter (mm) visual acuity score (left=no pain=0mm, right=worst possible pain=100mm)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-27.4","spread":null},{"groupId":"OG001","value":"-26.9","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline Sore Throat Pain Intensity up to 240 mn Post-dose","description":"100 milimeter (mm) visual acuity score (left=no pain=0mm, right=worst possible pain=100mm). It measures the highest pain level felt by the patient.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-25.5","spread":null},{"groupId":"OG001","value":"-29.1","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1,"n":125},"commonTop":["Headache","Throat Irritation","Asthma","dizziness","hyperaesthesia"]}}}